Aerogen is a world leader in acute care aerosol drug delivery.
Over 20 million patients in 75 countries have benefitted from our high-performance vibrating mesh nebuliser technology for aerosol drug deliver.y
Headquartered in Galway, Ireland, Aerogen is a world leader in acute care aerosol drug delivery. Our purpose is to transform patient care through world-leading aerosol drug delivery.
With over 25 years of experience, 300 international patents and associated with over 200 clinical papers and publications, Aerogen technology has been used to treat 20 million patients in 75 countries worldwide1. Based on pioneering vibrating mesh technology, our primary product, the Aerogen Solo, is a vibrating mesh nebuliser and has become the gold standard for respiratory patient care across the hospital, from the emergency department to intensive care.
We have been operating in the Middle East since 2017, with offices in Dubai and Saudi Arabia. To learn more about our business in the Middle East, please email us at [email protected] and visit WWW.Aeogen.com.
Why work with us
Clients should choose Aerogen products over competitors due to our unparalleled expertise and innovation in acute care aerosol drug delivery. As a world leader in mesh nebulizer technology, Aerogen is committed to providing the most efficient, reliable, and clinically effective solutions for aerosol therapy. Our nebulizers are designed to deliver high-quality, consistent aerosol particles that ensure optimal drug delivery to the lungs, even for critically ill patients.
Aerogen’s proprietary mesh technology minimizes treatment time, reduces medication wastage, and enhances patient comfort. Our products are extensively tested, trusted by healthcare professionals worldwide, and backed by years of clinical evidence. Additionally, Aerogen’s commitment to patient safety, ease of use, and cost-effective solutions make us the preferred choice for hospitals and healthcare providers looking for cutting-edge, reliable respiratory care equipment.
